Madrigal Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapies for liver and metabolic diseases, including its treatment for nonalcoholic steatohepatitis (NASH/MASH).
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| PAULSON & CO. INC. (auto-surfaced) | 63 | Trimmed -18% | 1,392,188 | $728,768,652 | 23.4% |
| Bridgewater | 55 | Trimmed -80% | 3,920 | $2,052,002 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.